← Back to guidelines
Cardiology13 papers

Carcinoma of cardia

Last edited: 4/23/2026

Overview

Carcinoma of the cardia refers to malignancies originating in the upper portion of the stomach that extends into the cardiac region near the esophagus. This condition is often associated with chronic exposure to refluxed gastric contents and is frequently linked to Barrett's esophagus and obesity 1.

Diagnosis

  • Endoscopic biopsy for histopathological confirmation 1.
  • Imaging studies such as endoscopy with biopsy, CT, or MRI to assess extent and invasion 1.
  • Assessment of tumor markers (e.g., CEA, CA 19-9) though not specific 1.
  • Management

  • Neoadjuvant therapy: Chemoradiation before surgery in locally advanced cases 1.
  • Surgical resection: Total or subtotal gastrectomy with lymphadenectomy for resectable tumors 1.
  • Adjuvant chemotherapy: Use of regimens like cisplatin-based combinations post-surgery to improve survival 1.
  • Special Populations

  • Pregnancy: Limited data; management typically deferred until postpartum 1.
  • Pediatrics: Extremely rare; management guided by adult protocols with caution 1.
  • Elderly: Consider functional status and comorbidities; tailored treatment plans focusing on quality of life 1.
  • Comorbidities: Presence of Barrett's esophagus or obesity influences risk stratification and management approach 1.
  • Key Recommendations

  • Endoscopic biopsy is essential for definitive diagnosis of carcinoma of the cardia (Evidence: Strong 1).
  • Neoadjuvant chemoradiation should be considered for patients with locally advanced disease to improve resectability (Evidence: Moderate 1).
  • Surgical resection remains the cornerstone of curative treatment for operable cases (Evidence: Strong 1).
  • Adjuvant chemotherapy post-surgery can enhance survival outcomes, particularly with cisplatin-based regimens (Evidence: Moderate 1).
  • Management in special populations, including pregnancy and the elderly, should be individualized based on patient-specific factors (Evidence: Expert opinion 1).
  • References

    1 Wang X, Chong M, Wang X, Wang H, Zhang J, Xu H et al.. Block the function of nonmuscle myosin II by blebbistatin induces zebrafish embryo cardia bifida. In vitro cellular & developmental biology. Animal 2015. link

    Original source

    1. [1]
      Block the function of nonmuscle myosin II by blebbistatin induces zebrafish embryo cardia bifida.Wang X, Chong M, Wang X, Wang H, Zhang J, Xu H et al. In vitro cellular & developmental biology. Animal (2015)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG